Protease Inhibitor: Invirase (Saquinavir)

PROTEASE INHIBITOR: INVIRASE (SAQUINAVIR) What are Protease Inhibitors? P rotease inhibitors are a new type of antiretroviral (a drug that stops the reproduction of HIV in your body). Protease drugs work by blocking a part of HIV called protease. With protease blocked, HIV makes copies of virus that can't infect new cells. Studies (clinical trials) of protease inhibitors have shown that these drugs, taken alone or in combination with other antiretroviral drugs (AZT, ddl, ddC, d4T, 3TC ), can lower viral load (the amount of HIV in your blood) and raise T-cells (CD4 cells). The greatest effect has been seen in people taking combination therapy. However, it's important to remember that more studies are needed to better understand how to use these drugs. When Should I Start Taking Protease Inhibitors? No one knows exactly when is the best time to begin taking protease inhibitors. Several studies of people who have low T-cells (100 or lower) have found that those who add a protease inhibitor along to other HIV medicine get about half as sick as those who do not. Based on these results, if you have: 1) low T-cells, 2) high viral load, 3) symptoms of illness, and/or 4) have had HIV disease for a long time, you may want to talk with your doctor about starting a combination that inclues a protease inhibitor. Doctors have not yet confirmed that taking these drugs early in HIV disease-when T-cells are high and viral load is low-will help prolong life or prevent the development of AIDS. In theory, starting a protease inhibitor when viral load is low will allow the drug to be more effective. Can Drug Resistance Occur with Protease Inhibitors? Yes. HIV eventually learns to work around the effect of the drug. This is called drug resistance. Resistance causes the drug to work less well or not to work at all. Resistant HIV may not go away, even if you stop taking the drug. Also, developing HIV that has resistance to one antiprotease drug will often mean that the HIV is resistant to other such drugs as well. This is called cross-resistance. Some studies show that taking protease inhibitors in combination with other anti-HIV drugs may greafly reduce the chance of developing resistance by further controlling the virus. To avoid or delay the development of drug food guidelines and not taking the drugs on schedule weakens the drugs' effect. HIV can then reproduce more. The more HIV reproduces, the better its chance to develop drug resistance. If you think that you are not able to follow the treatment routine which you and your doctor have put together, then you might want to wait until you are better prepared to take the drugs properly. Invirase (also called saquinavir): Dose Three 200 mg capsules taken three times a day within two hours after eating a full meal, preferably high in fat. Invirase must be taken on a full stomach to be effective. Some healthier foods that are high in fat include: lean red meat, peanut butter, avocado, cheese, bread with butter, whole or 2 percent milk products. Unlike other protease inhibitors, Invirase has been shown to be effective only when used in combination with other anti-viral drugs, including AZT, ddC or AZT/ddC. Talk with your doctor about which combination and which doses are best for you. Clinical studies have shown that Invirase is not as potent as other protease inhibitors in lowering the level of virus in the blood. This is mostly due to the fact that Invirase is poorly absorbed into the blood. A new, improved version of Invirase (the soft gel capsule) will be available in late 1997 that will increase the levels of Invirase in the blood eight or nine times. Another way to increase the level of Invirase in the blood is to take it in combination with the Abbott protease inhibitor, Norvir. Norvir greatly reduces the breakdown of Invirase by the liver. Studies have found that this combination is highly effective against HIV. Other trials are now looking at combining the new version of Invirase with either Norvir or Viracept, a protease inhibitor with an effect on the liver that is somewhat weaker than Norvir's. Storage Keep capsules in their bottle at room temperature. Side Effects Invirase has fewer side effects than other the other protease drugs. Side effects might include diarrhea, stomach upset, and nausea. However, most people in the clinical studies did not develop these problems. Cost Invirase sells for about $7,800.00 a year. Most Medicaid programs and private insurers reimburse the cost of the drug. The ADAP programs in New York and many other states also pay for Invirase. Hoffman-La Roche, the maker of Invirase, has a patient assistance program for people who are not covered by insurance and who cannot furthe informaion, cl 1-800-282-7780.JEt4II ~7 'L I7 I Availability Invirase is an approved drug and is available through any pharmacy. Inirseshud IOTbetae wih ifam in r.1fbti (y 91ti terfnadie (eldae), ste izo 9* aalpenbi talpheny in (Dln in),dexm.hasI.9eadrn For other Fact Sheets or for more information, contact GMHC, Department of Treatment Education and Advocacy, 119 West 24th Street, New York, NY 10011 (212) 367-1455

/ 2

Actions

file_download Download Options Download this page PDF - Pages 1-2 Image - Page 1 Plain Text - Page 1

About this Item

Title
Protease Inhibitor: Invirase (Saquinavir)
Author
Gay Men’s Health Crisis, Inc.
Canvas
Page 1 - Title Page
Publication
undated
Subject terms
brochures
Item type:
brochures

Technical Details

Link to this Item
https://name.umdl.umich.edu/5571095.0291.001
Link to this scan
https://quod.lib.umich.edu/c/cohenaids/5571095.0291.001/1

Rights and Permissions

The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.

Manifest
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0291.001

Cite this Item

Full citation
"Protease Inhibitor: Invirase (Saquinavir)." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0291.001. University of Michigan Library Digital Collections. Accessed May 11, 2025.
Do you have questions about this content? Need to report a problem? Please contact us.